Clinical Cancer Drugs
Title:Editorial
Volume: 1
Author(s): Yuval Shaked
Affiliation:
Export Options
About this article
Cite this article as:
Shaked Yuval, Editorial , Clinical Cancer Drugs 2014; 1 (1) . https://dx.doi.org/10.2174/2212697X01999131126150331
DOI https://dx.doi.org/10.2174/2212697X01999131126150331 |
Print ISSN 2212-697X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-6988 |
23
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Fcγ Receptor 1 (CD64), a Target Beyond Cancer
Current Pharmaceutical Design Impacts of Amine Functionalized Iron Oxide Nanoparticles on HepG2 Cell Line
Current Nanoscience NBN Polymorphysms and Cancer Susceptibility: A Systematic Review
Current Genomics CXCR3, CXCR5, CXCR6, and CXCR7 in Diabetes
Current Drug Targets Building Successful Relationships in the PLCO Cancer Screening Trial
Reviews on Recent Clinical Trials Purinergic Receptors and Pain
Current Pharmaceutical Design Immune Disturbances in Chronic Pain: Cause, Consequence or Both?
Current Immunology Reviews (Discontinued) TRP Channels in Respiratory Pathophysiology: the Role of Oxidative, Chemical Irritant and Temperature Stimuli
Current Neuropharmacology Novel Agents in the Management of Lung Cancer
Current Medicinal Chemistry Estrogen(s) and Analogs as a Non-Immunogenic Endogenous Ligand in Targeted Drug/DNA Delivery
Current Medicinal Chemistry The Use of DNA Microarrays to Investigate the Pharmacogenomics of Drug Response in Living Systems
Current Topics in Medicinal Chemistry Αlpha-2 Adrenergic and Opioids Receptors Participation in Mice Gastroprotection of Abelmoschus esculentus Lectin
Current Pharmaceutical Design Hyaluronic Acid as a Protein Polymeric Carrier: An Overview and a Report on Human Growth Hormone
Current Drug Targets Par-4 for Molecular Therapy of Prostate Cancer
Current Drug Targets Anti-inflammatory and Antioxidant Agents from Salvia Genus (Lamiaceae): An Assessment of the Current State of Knowledge
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Programming Apoptosis and Autophagy with Novel Approaches for Diabetes Mellitus
Current Neurovascular Research An Update of the Oxidation-Inflammation Theory of Aging: The Involvement of the Immune System in Oxi-Inflamm-Aging
Current Pharmaceutical Design Thomsen-Friedenreich Disaccharide Immunogenicity
Current Cancer Drug Targets Editorial (Thematic Issue: Application of Novel Computational Methods in Molecular Biology, Biomedicine and Biopharmacy)
Current Bioinformatics TiO<sub>2</sub>~Deoxyribozyme Nanocomposites as Delivery System and Efficient Site-Specific Agents for Cleavage of RNA Targets
Drug Delivery Letters